Swift Outpatient Alternatives for Rapid Stabilization (SOARS)
快速稳定门诊替代方案 (SOARS)
基本信息
- 批准号:10575209
- 负责人:
- 金额:$ 81.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-17 至 2028-01-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcuteAddressAdolescent and Young AdultAdoptionAgeBehaviorCaregiversCaringCause of DeathCharacteristicsCommunicationComplexDataDecision MakingDevelopmentDistressEffectivenessEngineeringEvaluationEvidence based interventionExperimental DesignsFamilyFeeling suicidalHealth PersonnelHealthcareHealthcare SystemsHospitalizationHybridsIndividualInterventionMediationMedicalMental Health ServicesModelingOutpatientsParentsPathway interactionsPatientsPatternPreventionPrevention ResearchProcessProliferatingProviderPublic HealthRecording of previous eventsReportingRisk FactorsRisk ManagementRisk ReductionSelf EfficacySuicideSuicide preventionTestingTherapeuticTimeUnited StatesYouthbarrier to carebehavioral healthcare providersdesignevidence baseexpectationhuman centered designimplementation outcomesimplementation trialimprovedmodifiable riskmortalitymulti-component interventionmultiphase optimization strategynovelpreventprimary care settingreducing suicidereferral servicesresponseskillsskills trainingsuicidalsuicidal adolescentsuicidal behaviorsuicidal morbiditysuicidal risktreatment optimizationtreatment planningusability
项目摘要
Suicide is a leading cause of death for youth and prevention efforts embedded in healthcare systems have
promise for reducing this substantial public health problem. There is a significant gap between the expectations
of a suicide care pathway and existing capacity and could be improved with optimized intervention packages
that address key stakeholders- youth, patient, behavioral health providers, and outpatient medical providers-
needs. Building upon promising pilot results, this project seeks to evaluate components of the Swift Outpatient
Alternative for Rapid Stabilization (SOARS) intervention to build the strongest combination to reduce youth
suicidal thoughts and behaviors (STB; Aim 1). We will test the impact patient characteristics (Aim 2) and if
SOARS components function through their putative mechanisms. The optimized treatment package will be
refined through co-design with providers to augment its acceptability and usability (Aim 4). Results will be
used to create an optimized intervention package to accelerate the pace of adoption by healthcare systems
and reduction of youth STBs. This will result in a youth suicide care intervention package optimized for
ecological validity, effectiveness and efficiency, and ready for evaluation in a hybrid implementation trial.
自杀是青少年死亡的主要原因,卫生保健系统中的预防工作已经取得了很大进展
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Molly Adrian其他文献
Molly Adrian的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Molly Adrian', 18)}}的其他基金
Advancing Suicide Intervention Strategies for Teens During High Risk Periods
推进高危时期青少年的自杀干预策略
- 批准号:
10208571 - 财政年份:2021
- 资助金额:
$ 81.37万 - 项目类别:
Advancing Suicide Intervention Strategies for Teens During High Risk Periods
推进高危时期青少年的自杀干预策略
- 批准号:
10656436 - 财政年份:2021
- 资助金额:
$ 81.37万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 81.37万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 81.37万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 81.37万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 81.37万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 81.37万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 81.37万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 81.37万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 81.37万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 81.37万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 81.37万 - 项目类别:
Operating Grants